Danaher Co. (NYSE:DHR) CFO Daniel L. Comas sold 62,989 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $101.96, for a total value of $6,422,358.44. Following the completion of the transaction, the chief financial officer now directly owns 227,805 shares in the company, valued at approximately $23,226,997.80. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Shares of Danaher Co. (NYSE DHR) traded up $0.95 during midday trading on Monday, reaching $95.41. The company’s stock had a trading volume of 2,250,000 shares, compared to its average volume of 2,870,000. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82. The stock has a market cap of $66,370.00, a P/E ratio of 27.26, a price-to-earnings-growth ratio of 1.99 and a beta of 1.04.
Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company had revenue of $5.09 billion for the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter in the prior year, the business earned $1.05 EPS. Danaher’s revenue was up 10.9% on a year-over-year basis. analysts anticipate that Danaher Co. will post 4.37 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were issued a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. Danaher’s payout ratio is currently 16.00%.
DHR has been the topic of several recent analyst reports. Credit Suisse Group reaffirmed a “hold” rating and issued a $99.00 price target on shares of Danaher in a research note on Tuesday, December 19th. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Robert W. Baird reissued a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Royal Bank of Canada reissued a “hold” rating and set a $96.00 target price on shares of Danaher in a research note on Thursday, January 4th. Finally, Morgan Stanley increased their target price on Danaher from $95.00 to $98.00 and gave the stock an “overweight” rating in a research note on Friday, October 20th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $100.13.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Calton & Associates Inc. purchased a new position in Danaher during the 4th quarter worth approximately $114,000. GQG Partners LLC purchased a new position in Danaher during the 2nd quarter worth approximately $101,000. First Personal Financial Services grew its stake in Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock worth $114,000 after buying an additional 691 shares during the last quarter. Zions Bancorporation grew its stake in Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock worth $106,000 after buying an additional 667 shares during the last quarter. Finally, Resources Investment Advisors Inc. grew its stake in Danaher by 661.2% during the 4th quarter. Resources Investment Advisors Inc. now owns 1,530 shares of the conglomerate’s stock worth $142,000 after buying an additional 1,329 shares during the last quarter. Institutional investors and hedge funds own 75.88% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Daniel L. Comas Sells 62,989 Shares of Danaher Co. (DHR) Stock” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/12/danaher-co-dhr-cfo-daniel-l-comas-sells-62989-shares.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.